Technology
Zicix Corporation(ZICX)
Live Price
Offline$0.68
+0.00% today
1Y Change
-88.67%
Window
Jun 23, 2025 โ Jun 19, 2026
- Market Cap
- $10.00M
- Revenue Growth
- 0.0%
- EPS Growth
- -134900.0%
- Dividend Yield
- 0.0%
Coverage: 255 bars ยท Jun 23, 2025 โ Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zicix Corporation (ZICX) is a Technology stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.68 and down 88.7% across the available one-year price window (Jun 23, 2025 โ Jun 19, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -134900.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -134900.0%, free cash flow +99.3% with operating margin -68.5% and ROIC -300.3%. Valuation already assumes a fairly strong business story at price/sales 8.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZICX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +11.9% peer median
Operating Margin
Below sector median
-68.5% vs +22.0% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Feb 20, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -134900.0%, with operating margin around -68.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +5.6% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 20, 2026 | โ | +0.0% | +0.0% | -67.4% |
2025 Nov 14, 2025 | โ | -2.7% | +0.2% | +1.0% |
2025 May 21, 2025 | โ | +10.0% | +16.7% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZICX
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
ZICX Max Drawdown
-97.86%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ZICX and SPY.
Company Overview
Zicix Corporation
Other OTC
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.
- Leadership
- Edwin Kai Ip Li
- IPO Date
- Oct 29, 2009
- Employees
- 2
- Street Address
- 710 North Post Oak Road
- Mailing
- Houston, TX, 77024
- Region
- Houston, TX, US
- Reporting Currency
- USD
- Investor Line
- 281-540-0500
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 8.8
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- -134900.0%
- Free Cash Flow
- +99.3%
Profitability
- Gross Margin
- 35.6%
- Operating Margin
- -68.5%
- Net Margin
- -138.0%
- ROE
- 53.5%
- ROIC
- -300.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.39
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.